- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Glenmark Pharmaceuticals Limited — Updates, 04-11-2025: Press Release
04-11-2025 | 08:57 am
04-11-2025 | 08:57 am
Glenmark Pharmaceuticals Inc., USA will launch 8.4% Sodium Bicarbonate Injection USP Single-Dose Vial, expanding its injectable portfolio. This market segment has annual sales of approximately $63.8 million, offering a new revenue stream for the company.
No comments yet. Be the first to comment!